Ana Vicente‐Sánchez

659 total citations
13 papers, 555 citations indexed

About

Ana Vicente‐Sánchez is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Ana Vicente‐Sánchez has authored 13 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Ana Vicente‐Sánchez's work include Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Ana Vicente‐Sánchez is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Ana Vicente‐Sánchez collaborates with scholars based in Spain, United States and France. Ana Vicente‐Sánchez's co-authors include Javier Garzón, Pilar Sánchez‐Blázquez, María Rodríguez-Muñoz, Esther Berrocoso, Amynah Pradhan, Laura Segura, Ricardo Martı́nez-Murillo, Brigitte Kieffer, Julie Perroy and Wendy Walwyn and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Neuroscience.

In The Last Decade

Ana Vicente‐Sánchez

13 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Vicente‐Sánchez Spain 11 389 269 153 147 47 13 555
Brian M. Kelley United States 14 344 0.9× 227 0.8× 88 0.6× 77 0.5× 28 0.6× 22 631
Ittai Bushlin United States 13 420 1.1× 453 1.7× 229 1.5× 195 1.3× 29 0.6× 19 809
Takeshi Iwazaki Australia 9 307 0.8× 154 0.6× 57 0.4× 218 1.5× 45 1.0× 9 537
Ditte Dencker Denmark 15 484 1.2× 481 1.8× 64 0.4× 54 0.4× 43 0.9× 21 689
Wenhua Han Japan 12 334 0.9× 340 1.3× 231 1.5× 57 0.4× 35 0.7× 16 648
Aliza T. Ehrlich Canada 13 302 0.8× 248 0.9× 77 0.5× 41 0.3× 27 0.6× 19 499
Karin Hygge Blakeman Sweden 12 449 1.2× 261 1.0× 267 1.7× 42 0.3× 53 1.1× 24 697
David León Spain 16 260 0.7× 165 0.6× 66 0.4× 71 0.5× 86 1.8× 44 645
Louise Witten Denmark 9 172 0.4× 142 0.5× 41 0.3× 120 0.8× 55 1.2× 11 402
Melissa T. Manners United States 12 164 0.4× 123 0.5× 79 0.5× 134 0.9× 14 0.3× 17 431

Countries citing papers authored by Ana Vicente‐Sánchez

Since Specialization
Citations

This map shows the geographic impact of Ana Vicente‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Vicente‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Vicente‐Sánchez more than expected).

Fields of papers citing papers by Ana Vicente‐Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Vicente‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Vicente‐Sánchez. The network helps show where Ana Vicente‐Sánchez may publish in the future.

Co-authorship network of co-authors of Ana Vicente‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Vicente‐Sánchez. A scholar is included among the top collaborators of Ana Vicente‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Vicente‐Sánchez. Ana Vicente‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Vicente‐Sánchez, Ana, et al.. (2018). Tolerance to high‐internalizing δ opioid receptor agonist is critically mediated by arrestin 2. British Journal of Pharmacology. 175(14). 3050–3059. 36 indexed citations
2.
Bastida, José María, Oriana López‐Godino, Ana Vicente‐Sánchez, et al.. (2018). Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology. International Journal of Laboratory Hematology. 41(1). 109–117. 6 indexed citations
3.
Vicente‐Sánchez, Ana & Amynah Pradhan. (2017). Ligand-Directed Signaling at the Delta Opioid Receptor. Handbook of experimental pharmacology. 247. 73–85. 7 indexed citations
4.
Vicente‐Sánchez, Ana, Laura Segura, & Amynah Pradhan. (2016). The delta opioid receptor tool box. Neuroscience. 338. 145–159. 28 indexed citations
5.
Pradhan, Amynah, Julie Perroy, Wendy Walwyn, et al.. (2016). Agonist-Specific Recruitment of Arrestin Isoforms Differentially Modify Delta Opioid Receptor Function. Journal of Neuroscience. 36(12). 3541–3551. 53 indexed citations
6.
Garzón, Javier, Raquel Herrero-Labrador, María Rodríguez-Muñoz, et al.. (2014). HINT1 protein: A new therapeutic target to enhance opioid antinociception and block mechanical allodynia. Neuropharmacology. 89. 412–423. 35 indexed citations
7.
Vicente‐Sánchez, Ana, Pilar Sánchez‐Blázquez, María Rodríguez-Muñoz, & Javier Garzón. (2013). HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity. Molecular Brain. 6(1). 42–42. 44 indexed citations
8.
Sánchez‐Blázquez, Pilar, María Rodríguez-Muñoz, Ana Vicente‐Sánchez, & Javier Garzón. (2013). Cannabinoid Receptors Couple to NMDA Receptors to Reduce the Production of NO and the Mobilization of Zinc Induced by Glutamate. Antioxidants and Redox Signaling. 19(15). 1766–1782. 67 indexed citations
9.
Rodríguez-Muñoz, María, Pilar Sánchez‐Blázquez, Ana Vicente‐Sánchez, Esther Berrocoso, & Javier Garzón. (2011). The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control. Neuropsychopharmacology. 37(2). 338–349. 145 indexed citations
10.
Garzón, Javier, María Rodríguez-Muñoz, Ana Vicente‐Sánchez, et al.. (2011). SUMO-SIM Interactions Regulate the Activity of RGSZ2 Proteins. PLoS ONE. 6(12). e28557–e28557. 12 indexed citations
11.
12.
Rodríguez-Muñoz, María, et al.. (2010). The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor–glutamate NMDA receptor cross-regulation. Cellular and Molecular Life Sciences. 68(17). 2933–2949. 51 indexed citations
13.
Garzón, Javier, et al.. (2009). Gz Mediates the Long-Lasting Desensitization of Brain CB1 Receptors and is Essential for Cross-Tolerance with Morphine. Molecular Pain. 5. 11–11. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian M. Kelley Breakdown of academic impact, for papers by Ittai Bushlin Breakdown of academic impact, for papers by Takeshi Iwazaki Breakdown of academic impact, for papers by Ditte Dencker Breakdown of academic impact, for papers by Wenhua Han Breakdown of academic impact, for papers by Aliza T. Ehrlich Breakdown of academic impact, for papers by Karin Hygge Blakeman Breakdown of academic impact, for papers by David León Breakdown of academic impact, for papers by Louise Witten Breakdown of academic impact, for papers by Melissa T. Manners
Rankless by CCL
2026